Gary W Pace - Net Worth and Insider Trading
Gary W Pace Net Worth
The estimated net worth of Gary W Pace is at least $28 Million dollars as of 2024-11-05. Gary W Pace is the Director of ResMed Inc and owns about 100,578 shares of ResMed Inc (RMD) stock worth over $25 Million. Gary W Pace is the Director of Cardiff Oncology Inc and owns about 697,761 shares of Cardiff Oncology Inc (CRDF) stock worth over $3 Million. Gary W Pace is also the Director of Pacira BioSciences Inc and owns about 22,127 shares of Pacira BioSciences Inc (PCRX) stock worth over $370,185. Details can be seen in Gary W Pace's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gary W Pace has not made any transactions after 2024-03-08 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gary W Pace
Gary W Pace Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gary W Pace owns 4 companies in total, including Pacira BioSciences Inc (PCRX) , Cardiff Oncology Inc (CRDF) , and ResMed Inc (RMD) among others .
Click here to see the complete history of Gary W Pace’s form 4 insider trades.
Insider Ownership Summary of Gary W Pace
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCRX | Pacira BioSciences Inc | 2024-03-08 | director |
| CRDF | Cardiff Oncology Inc | 2023-12-19 | director |
| RMD | ResMed Inc | 2018-05-08 | director |
 | | 2006-03-15 | director |
Gary W Pace Latest Holdings Summary
Gary W Pace currently owns a total of 3 stocks. Among these stocks, Gary W Pace owns 100,578 shares of ResMed Inc (RMD) as of May 8, 2018, with a value of $25 Million and a weighting of 89.23%. Gary W Pace owns 697,761 shares of Cardiff Oncology Inc (CRDF) as of December 19, 2023, with a value of $3 Million and a weighting of 9.42%. Gary W Pace also owns 22,127 shares of Pacira BioSciences Inc (PCRX) as of March 8, 2024, with a value of $370,185 and a weighting of 1.35%.
Latest Holdings of Gary W Pace
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RMD | ResMed Inc | 2018-05-08 | 100,578 | 244.08 | 24,548,575 |
| CRDF | Cardiff Oncology Inc | 2023-12-19 | 697,761 | 3.72 | 2,592,182 |
| PCRX | Pacira BioSciences Inc | 2024-03-08 | 22,127 | 16.73 | 370,185 |
Holding Weightings of Gary W Pace
Gary W Pace Form 4 Trading Tracker
According to the SEC Form 4 filings, Gary W Pace has made a total of 0 transactions in ResMed Inc (RMD) over the past 5 years. The most-recent trade in ResMed Inc is the sale of 28,403 shares on May 8, 2018, which brought Gary W Pace around $3 Million.
According to the SEC Form 4 filings, Gary W Pace has made a total of 9 transactions in Cardiff Oncology Inc (CRDF) over the past 5 years, including 9 buys and 0 sells. The most-recent trade in Cardiff Oncology Inc is the acquisition of 30,000 shares on December 19, 2023, which cost Gary W Pace around $41,100.
According to the SEC Form 4 filings, Gary W Pace has made a total of 3 transactions in Pacira BioSciences Inc (PCRX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Pacira BioSciences Inc is the sale of 119,323 shares on March 8, 2024, which brought Gary W Pace around $4 Million.
Insider Trading History of Gary W Pace
- 1
Gary W Pace Trading Performance
GuruFocus tracks the stock performance after each of Gary W Pace's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Gary W Pace is 62.71%. GuruFocus also compares Gary W Pace's trading performance to market benchmark return within the same time period. The performance of stocks bought by Gary W Pace within 3 months outperforms 6 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Gary W Pace's insider trading performs compared to the benchmark.
Performance of Gary W Pace
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.12 | | | | | |
| Relative Return to S&P 500(%) | 16.07 | | | | | |
Gary W Pace Ownership Network
Ownership Network List of Gary W Pace
Ownership Network Relation of Gary W Pace
Gary W Pace Owned Company Details
What does Pacira BioSciences Inc do?
Who are the key executives at Pacira BioSciences Inc?
Gary W Pace is the director of Pacira BioSciences Inc. Other key executives at Pacira BioSciences Inc include Chief Operating Officer Daryl Gaugler , Chief Clinical Officer Jonathan Slonin , and CAO and General Counsel Kristen Marie Williams .
Pacira BioSciences Inc (PCRX) Insider Trades Summary
Over the past 18 months, Gary W Pace made 2 insider transaction in Pacira BioSciences Inc (PCRX) with a net sale of 124,338. Other recent insider transactions involving Pacira BioSciences Inc (PCRX) include a net sale of 12,186 shares made by Lauren Bullaro Riker , a net sale of 9,754 shares made by Jonathan Slonin , and a net sale of 7,052 shares made by Daryl Gaugler .
In summary, during the past 3 months, insiders sold 500 shares of Pacira BioSciences Inc (PCRX) in total and bought 20,976 shares, with a net purchase of 20,476 shares. During the past 18 months, 224,391 shares of Pacira BioSciences Inc (PCRX) were sold and 20,976 shares were bought by its insiders, resulting in a net sale of 203,415 shares.
Pacira BioSciences Inc (PCRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pacira BioSciences Inc Insider Transactions
Gary W Pace Mailing Address
Above is the net worth, insider trading, and ownership report for Gary W Pace. You might contact Gary W Pace via mailing address: C/o Resmed Inc, 14040 Danielson Street, Poway Ca 92064-6857.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
